Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   

COVID-19: Daily Top 10 Papers

  Bladder Cancer

  Free Subscription


1 Ann Work Expo Health
1 Anticancer Res
1 Cancer Invest
1 Cancer Res Treat
1 Cancer Sci
2 Cancers (Basel)
1 Chem Biol Drug Des
1 Curr Urol Rep
1 Diagn Cytopathol
2 Eur Urol
1 Front Mol Biosci
1 Gene
1 Indian J Pathol Microbiol
1 Int J Mol Med
1 Integr Cancer Ther
1 J Clin Lab Anal
3 J Endourol
2 J Robot Surg
1 J Urol
1 Mol Pharm
1 Neoplasma
1 Nucleic Acids Res
1 Nutr Cancer
1 Scand J Urol
1 Sci Rep
1 Stem Cell Res Ther
1 Turk Patoloji Derg
1 Urol Oncol
1 Vaccine
1 World J Urol

  Retrieve available abstracts of this week’s articles:
HTML format
Single Articles

    Ann Work Expo Health

  1. JOSSE PR, Koutros S, Tardon A, Rothman N, et al
    Adapting Decision Rules to Estimate Occupational Metalworking Fluid Exposure in a Case-Control Study of Bladder Cancer in Spain.
    Ann Work Expo Health. 2021 Oct 9. pii: 6384957. doi: 10.1093.
    PubMed         Abstract available

    Anticancer Res

  2. PAN Y, Hong YC, Hsiao CH, Shih HJ, et al
    Effects of Concurrent Chemoradiotherapy on the Metastasis and the Mesenchymal Transition of Bladder Urothelial Carcinoma Cells.
    Anticancer Res. 2021;41:4957-4968.
    PubMed         Abstract available

    Cancer Invest

  3. FU J DR, Wang Y Dr
    Identification of a novel pyroptosis-related gene signature for predicting prognosis in bladder cancer.
    Cancer Invest. 2021 Oct 13:1-24. doi: 10.1080/07357907.2021.1991944.
    PubMed         Abstract available

    Cancer Res Treat

  4. SUH J, Han D, Ku JH, Kim HH, et al
    Next-generation Proteomics-Based Discovery, Verification, and Validation of Urine Biomarkers for Bladder Cancer Diagnosis.
    Cancer Res Treat. 2021 Oct 9. pii: crt.2021.642. doi: 10.4143/crt.2021.
    PubMed         Abstract available

    Cancer Sci

  5. LIU X, Liu S, Piao C, Zhang Z, et al
    Non-metabolic function of MTHFD2 activates CDK2 in bladder cancer.
    Cancer Sci. 2021 Oct 10. doi: 10.1111/cas.15159.
    PubMed         Abstract available

    Cancers (Basel)

  6. XIAO JF, Caliri AW, Duex JE, Theodorescu D, et al
    Targetable Pathways in Advanced Bladder Cancer: FGFR Signaling.
    Cancers (Basel). 2021;13.
    PubMed         Abstract available

  7. RUBIO-BRIONES J, Algaba F, Gallardo E, Marcos-Rodriguez JA, et al
    Recent Advances in the Management of Patients with Non-Muscle-Invasive Bladder Cancer Using a Multidisciplinary Approach: Practical Recommendations from the Spanish Oncology Genitourinary (SOGUG) Working Group.
    Cancers (Basel). 2021;13.
    PubMed         Abstract available

    Chem Biol Drug Des

  8. HU H, Zhou H, Xu D
    A review of the effects and molecular mechanisms of dimethylcurcumin (ASC-J9) on androgen receptor-related diseases.
    Chem Biol Drug Des. 2021;97:821-835.
    PubMed         Abstract available

    Curr Urol Rep

  9. NG CHIENG HIN J, Hettiarachchilage D, Gravestock P, Rai B, et al
    Role of Ureteroscopy in Treatment of Upper Tract Urothelial Carcinoma.
    Curr Urol Rep. 2021;22:49.
    PubMed         Abstract available

    Diagn Cytopathol

  10. YOO Y, Choi E, Lee DH, Park S, et al
    Diagnostic value of urine cytology in detecting histologic variants of urothelial carcinomas in the urinary bladder: Cytopathologic correlation of 72 cases.
    Diagn Cytopathol. 2021;49:367-373.
    PubMed         Abstract available

    Eur Urol

  11. BEDKE J, Maas M
    Re: Enfortumab Vedotin in Previously Treated Advanced Urothelial Carcinoma.
    Eur Urol. 2021;80:257-258.

    Re: Complications Associated with Ureteroscopic Management of Upper Tract Urothelial Carcinoma.
    Eur Urol. 2021;80:255.

    Front Mol Biosci

  13. ZHUANG C, Liu Y, Fu S, Yuan C, et al
    Corrigendum: Silencing of lncRNA MIR497HG via CRISPR/Cas13d Induces Bladder Cancer Progression Through Promoting the Crosstalk Between Hippo/Yap and TGF-beta/Smad Signaling.
    Front Mol Biosci. 2021;8:664616.
    PubMed         Abstract available


  14. YAN J, Yu W, Lu C, Liu C, et al
    High ORAI3 expression correlates with good prognosis in human muscle-invasive bladder cancer.
    Gene. 2021 Oct 6:145994. doi: 10.1016/j.gene.2021.145994.
    PubMed         Abstract available

    Indian J Pathol Microbiol

  15. JINDAL T, Dey D, Pawar P, Subedi N, et al
    Ureteric sarcomatoid urothelial carcinoma with chondrosarcomatous differentiation: A rare entity.
    Indian J Pathol Microbiol. 2021;64:418-419.

    Int J Mol Med

  16. LI K, Li S, Tang S, Zhang M, et al
    KIF22 promotes bladder cancer progression by activating the expression of CDCA3.
    Int J Mol Med. 2021;48.
    PubMed         Abstract available

    Integr Cancer Ther

  17. COZZI G, Musi G, Milani M, Jemos C, et al
    Impact of Perioperative Immunonutrition on Complications in Patients Undergoing Radical Cystectomy: A Retrospective Analysis.
    Integr Cancer Ther. 2021;20:15347354211019483.
    PubMed         Abstract available

    J Clin Lab Anal

  18. XU G, Huang R, Xia W, Jiang B, et al
    Associations between inflammasome-related gene NLRP3 Polymorphisms (rs10754558 and rs35829419) and risk of bladder cancer in a Chinese population.
    J Clin Lab Anal. 2021 Oct 12:e23973. doi: 10.1002/jcla.23973.
    PubMed         Abstract available

    J Endourol

  19. TANG Y, Kortum A, Vohra I, Schwarz RA, et al
    Initial Results of First In Vivo Imaging of Bladder Lesions Using a High-Resolution Confocal Microendoscope.
    J Endourol. 2021;35:1190-1197.
    PubMed         Abstract available

  20. MULAWKAR P, Sharma G, Garge P
    Evaluation of Spectra A and B Modes in Diagnosis of Suspicious Bladder Lesions.
    J Endourol. 2021;35:1184-1189.
    PubMed         Abstract available

  21. GROSS JT, Vetter JM, Sands KG, Palka JK, et al
    Initial Experience with Single-Port Robot-Assisted Radical Cystectomy: Comparison of Perioperative Outcomes Between Single-Port and Conventional Multiport Approaches.
    J Endourol. 2021;35:1177-1183.
    PubMed         Abstract available

    J Robot Surg

  22. TANNERU K, Jazayeri SB, Kumar J, Alam MU, et al
    Intracorporeal versus extracorporeal urinary diversion following robot-assisted radical cystectomy: a meta-analysis, cumulative analysis, and systematic review.
    J Robot Surg. 2021;15:321-333.
    PubMed         Abstract available

  23. ROCCO B, Luciani LG, Collins J, Sanchez-Salas R, et al
    Posterior reconstruction during robotic-assisted radical cystectomy with intracorporeal orthotopic ileal neobladder: description and outcomes of a simple step.
    J Robot Surg. 2021;15:355-361.
    PubMed         Abstract available

    J Urol

  24. LOTAN Y, de Jong J, Liu VYT, Bismar TA, et al
    Patients With Muscle Invasive Bladder Cancer with Non-luminal Subtype Derive Greatest Benefit from Platinum Based Neoadjuvant Chemotherapy.
    J Urol. 2021 Oct 13:101097JU0000000000002261. doi: 10.1097/JU.0000000000002261.
    PubMed         Abstract available

    Mol Pharm

  25. ZHOU Q, Ding W, Qian Z, Zhu Q, et al
    Immunotherapy Strategy Targeting Programmed Cell Death Ligand 1 and CD73 with Macrophage-Derived Mimetic Nanovesicles to Treat Bladder Cancer.
    Mol Pharm. 2021 Oct 14. doi: 10.1021/acs.molpharmaceut.1c00448.
    PubMed         Abstract available


  26. LI WJ, Li G, Liu ZW, Chen ZY, et al
    LncRNA LINC00355 promotes EMT and metastasis of bladder cancer cells through the miR-424-5p/HMGA2 axis.
    Neoplasma. 2021 Oct 11. pii: 210427N574. doi: 10.4149/neo_2021_210427.
    PubMed         Abstract available

    Nucleic Acids Res

  27. RICHART L, Lapi E, Pancaldi V, Cuenca-Ardura M, et al
    STAG2 loss-of-function affects short-range genomic contacts and modulates the basal-luminal transcriptional program of bladder cancer cells.
    Nucleic Acids Res. 2021 Oct 14. pii: 6396892. doi: 10.1093.
    PubMed         Abstract available

    Nutr Cancer

  28. AZZI J, Waked A, Bou-Gharios J, Al Choboq J, et al
    Radiosensitizing Effect of Curcumin on Human Bladder Cancer Cell Lines: Impact on DNA Repair Mechanisms.
    Nutr Cancer. 2021 Oct 13:1-15. doi: 10.1080/01635581.2021.1985534.
    PubMed         Abstract available

    Scand J Urol

    Personalized medicine for bladder cancer.
    Scand J Urol. 2021;55:419.

    Sci Rep

  30. EBERHARD J, Hirsch D, Schilling O, Dirks WG, et al
    First report on establishment and characterization of a carcinosarcoma tumour cell line model of the bladder.
    Sci Rep. 2021;11:6030.
    PubMed         Abstract available

    Stem Cell Res Ther

  31. CHUNG WM, Molony RD, Lee YF
    Non-stem bladder cancer cell-derived extracellular vesicles promote cancer stem cell survival in response to chemotherapy.
    Stem Cell Res Ther. 2021;12:533.
    PubMed         Abstract available

    Turk Patoloji Derg

  32. HACIHASANOGLU E, YUcetaS U, OkCu O, BehzatoGlu K, et al
    Stromal Lymphoid Response Status in Micropapillary Urothelial Carcinomas Diagnosed in Bladder Transurethral Resections and its Comparison with Conventional Urothelial Carcinomas.
    Turk Patoloji Derg. 2021;37:26-31.
    PubMed         Abstract available

    Urol Oncol

  33. VENKAT S, Khan AI, Taylor BL, Patel NA, et al
    Does neoadjuvant chemotherapy diminish the sex disparity in bladder cancer survival after radical cystectomy?
    Urol Oncol. 2021 Oct 7. pii: S1078-1439(21)00415.
    PubMed         Abstract available


  34. MUKHERJEE N, Julian E, Torrelles JB, Svatek RS, et al
    Effects of Mycobacterium bovis Calmette et Guerin (BCG) in oncotherapy: Bladder cancer and beyond.
    Vaccine. 2021 Oct 6. pii: S0264-410X(21)01256.
    PubMed         Abstract available

    World J Urol

    Latest Developments and Current Problems in Bladder Cancer.
    World J Urol. 2021 Oct 13. pii: 10.1007/s00345-021-03857.

Thank you for your interest in scientific medicine.

AMEDEO Bladder Cancer is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.